The sleep apnea implants market size is estimated to be valued at USD 317.1 million in 2023 and is expected to reach USD 1,158.1 million by 2033. The adoption of Sleep Apnea Implants is likely to advance at a CAGR of 13.8% during the forecast period.
The rising prevalence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a severe sleep disorder that may increase the risk of fatal accidents or other health-related complications caused due to disturbed sleep has necessitated innovation in Sleep Apnea Implants. Consequences of sleepiness and sleep deprivation are common among people who are shift workers and have headed to several sleep-related disorders. Problems such as OSA, insomnia, jet lag narcolepsy, and sleepwalking are a few of the sleep-related disorders which remain undiagnosed. For instance, according to a study published in the National Institutes of Health journal, around 30% of the adult American population suffers from insomnia and 10% from chronic
A large pool of the population affected by sleep apnea has become more awareness about these disorders and other related ailments. The increasing prevalence of sleep disorders has led to expansion in hospitals and other care centers in various areas, with the establishment of separate divisions dealing with sleep disorders. These sleep centers have increased awareness on tracking sleep patterns for better sleep. Sleep-related awareness is consistently contributing to the increase in the diagnosis rate of sleep disorders. This is expected to drive the sleep apnea implants market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for sleep apnea implants. The report tracks the global sales of sleep apnea implants in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and sleep apnea implants in particular.
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | USD 317.1 million |
| Projected Market Size (2033) | USD 1,158.1 million |
| CAGR through (2023 to 2033) | 13.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
OSA is a progressive disorder affecting more than 200 million people worldwide. According to a study in Lancet, 936 million (95% CI 903–970) adults aged 30–69 years (men and women) were suffering from mild to severe OSA globally. The highest number of affected cases was found in China, followed by the USA, Brazil, and India in 2019.
According to FMI’s analysis, sales of sleep apnea implants have grown at a 12.1% CAGR between 2018 and 2022. Sleep apnea implants have become a potential tool improving airflow and reducing sleep apnea in patients suffering from a sleep disorder. Hypoglossal neurostimulation devices have gained popularity based on their efficacy as compared to other products. FMI expects the global sleep apnea implants market to grow at a 13.8% CAGR through 2033.
| Period | Market Size (in USD million) |
|---|---|
| 2017 | USD 42.6 million |
| 2022 | USD 247.2 million |
| 2022 | USD 317.1 million |
| 2033 | USD 1,1158.1 million |
Unlocking the Dream: Exploring Lucrative Opportunities in the Sleep Apnea Implants Market
Manufacturers are actively focusing on research and development to innovate advanced devices that meet the customers’ demand and are likely to gain popularity with high revenue share in the competitive market. Advancements in sleep apnea devices include sleep trackers that track sleep patterns based on movement monitoring and also monitor the heart rate. For example, many companies are developing wearables that go on your wrist or finger while sleeping and collect data about the movement and heart rate, while some also track breathing patterns.
Developing countries, such as China and India, have a relatively large population base and the incidence of sleep-related disorders such as insomnia and sleep apnea is comparatively higher than that in other countries. Sleep-related disorders are a serious issue in China and India, which is an opportunity for the leading manufacturers to expand their business in the region and increase their market share. Thus, the rising prevalence of sleep-related disorders is expected to offer robust opportunities for the manufacturers in the sleep apnea implants market.
Nurturing a Silent Revolution: Government and Non-governmental Initiatives Powering Sleep Apnea Implants Sales
Numerous government and non-government organizations such as Circadian Sleep Disorders Network and the American Sleep Apnea Association (ASAA) conduct sleep awareness programs regarding the importance of ample sleep and usage of sleep apnea devices. These organizations are launching several awareness programs to educate people about sleep hygiene and technological aid to get better sleep. For example, Sleep Awareness Week was celebrated by the National Sleep Foundation with the theme “Begin with Sleep Moreover” in March 2018.
Various organizations are improving their services to offer greater customer satisfaction. For instance, the American Sleep Association is an organization dedicated to improving public health by increasing awareness about the importance of sleep and the dangers of sleep disorders. Government approval is expected to propel the sleep apnea implants market growth.
Due to an increase in the need for assessment of OSA breathe in peripheral artery disease and limb ischemia, many manufacturers seek 510(k) Premarket Notification from the USA. Food and Drug Administration (“FDA”) which demonstrates the device to be safe and effective, equivalent to a legally marketed device. For example, in May 2019, Siesta Medical, Inc. (Private) announced FDA clearance for expanded indications for its Encore™ Tongue Suspension System for the treatment of obstructive sleep apnea.
Implementing government guidelines for prescription reformation attracts end-users, which is expected to boost the demand for sleep apnea implants. For instance, in February 2021, the FDA authorized the marketing of eXciteOSA® (Signifier Medical Technologies), a new prescription intended to reduce sleep snoring and OSA in patients 18 years and older.
Unmasking the Barriers: Unlocking the Potential of Sleep Apnea Implants amidst Sales Impediments
Continuous positive airway pressure (CPAP) is the most popular technology adopted for the assessment of sleep deprivation-associated disorders. CPAP devices come in different price ranges depending upon the number of features. The high upfront cost can have a negative impact on the end users’ decision to purchase sleep apnea implants.
Some of the most effective sleep disorder treatments are quite expensive. As a general rule, the surgery associated with the placement of the Inspire hypoglossal nerve stimulator may cost USD30,000 to USD40,000 (with the device itself costing about USD20,000 of this total). Thus, high cost of the technology as well as the treatment is the major factor expected to hamper the market growth.
The healthcare system of the United States is highly renowned for its well-developed infrastructure and high expenditure. The care regimes in the care centers and hospitals are covered by regulatory rules and insurance policies. The massive hospital bills incurred other than Medicare escalate the market in the country.
The United States government and regulatory bodies are actively adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume-based to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk-sharing, competitive tendering, and price control.
A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments in the R&D of advanced medical treatment technologies. In June 2020, the IDE trial was approved by FDA, with the first United States and international implants.
Due to the high prevalence of sleep disorders in the United States, the government as well as non-government organizations are conducting campaigns to raise general awareness among people suffering from these diseases. This is likely to support the overall market growth in the country.
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. The health expenditure was expected to surge to 407.4 billion euros by 2019, presenting a lucrative landscape for the expansion of sleep apnea implants sales.
The presence of domestic players such as Carl Martin GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population, are covered by statutory health insurance. Another 11% of the population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive growth opportunities.
Increasing disposable income can have a significant impact on the development of the economy in emerging countries, which results in the affordability of proper healthcare treatments. China’s per capita disposable income reached about 4,961 USA. dollars in 2020, more than double that in 2010.
The potential for high healthcare insurance and rising disposable income will contribute to increasing affordability of healthcare services and also accessibility to expensive equipment for the treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 15.7% during the forecast period.
Lack of awareness about complete sleep and related disorders and lack of treatment or low adoption of therapy due to high cost raises the prevalence of sleep disorders in GCC Countries. Due to limited campaigning and assessment of the undiagnosed disorders, there seems to occur less usage of these devices in hospitals in GCC Countries.
Poor healthcare facilities in some countries restrain the growth of the sleep apnea implants market. Due to financial burdens, governments fail to provide proper treatment and are unable to facilitate campaigns to create awareness among the population, which may impact the usage of advanced devices. The market in GCC Countries is expected to witness sluggish growth during the forecast period.
Principal Consultant
The OSA segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold 91.34% of the market share, in terms of indication, by the end of 2033.
OSA is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep. The rising prevalence of OSA across the global population leads to a spike in share for the OSA segment in the market.
Hypoglossal Neurostimulation Devices hold the highest share in the sleep apnea implants market. Hypoglossal neurostimulation devices are meant to treat pharyngeal tone and stimulates genioglossus protrusion to the open airway by the tongue during sleep.
These devices reduce the risk for severe dysphagia and throat pain that witnessed by a surge in the demand for the device in the market.
The hospital segment is expected to dominate the sleep apnea implants market through the forecast period. Higher footfall of sleep apnea patients in hospitals will seal their position as the dominant end user.
In the ever-evolving realm of sleep apnea implants, a fierce competition unfolds as key players vie for supremacy. Industry frontrunners deploy innovative technologies, cutting-edge research, and strategic partnerships to gain a decisive edge. Titans clash as they strive to capture significant market shares, revolutionize treatment outcomes, and improve patient experiences.
Established giants showcase their prowess, while nimble startups disrupt the status quo with disruptive solutions. As the battle intensifies, companies tirelessly invest in R&D, focusing on implant efficacy, patient comfort, and remote monitoring capabilities. In this dynamic arena, the competitive landscape continuously evolves, forging new alliances, sparking acquisitions, and fueling innovation. Amidst this fierce contest, it is the sleep apnea sufferers who stand to benefit the most, as a relentless pursuit of excellence drives the industry towards a brighter future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Strategies for Sleep Apnea Implants Manufacturers to Expand in the Market
Product Portfolio:
Medtronic Plc offers a diverse product portfolio in the medical technology industry, including sleep apnea implants. Their range includes innovative and advanced implantable devices and therapy management systems designed to effectively treat sleep apnea and improve patients' quality of life.
LinguaFlex LLC specializes in providing a comprehensive product portfolio for the treatment of sleep apnea. Their offerings include unique and flexible tongue stabilization devices that help alleviate sleep apnea symptoms by supporting the tongue and improving airway flow, providing patients with effective and personalized treatment options.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 317.1 million |
| Market Value in 2033 | USD 1,158.1 million |
| Growth Rate | CAGR of 13.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Indication, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Singapore, Thailand, Indonesia, Australia, New Zealand, GCC, South Africa, Israel |
| Key Companies Profiled | Inspire Medical Systems; Respicardia, Inc.; Medtronic Plc; LinguaFlex LLC; Siesta Medical, Inc.; Pillar Palatal LLC / The Snoring Center; Nyxoah SA; LivaNova/ImThera |
| Customization & Pricing | Available upon Request |
The market is set to amount to USD 1,158.1 million by 2033.
The growth potential of the market is 13.8% through 2033.
Manufacturers are developing advanced devices to popularize their brands and gain a larger share.
American Sleep Apnea Association (ASAA) and Circadian Sleep Disorders Network are contributing to the product demand.
Developments in neurostimulation technology have a prominent influence on the market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Phrenic Nerve Stimulator 5.2. Hypoglossal Neurostimulation Devices 5.3. Bone Screw Implant System 5.4. Flexible Tongue Retractor System 5.5. Palatal Implants/Pillar Procedure 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Central Sleep Apnea 6.2. Obstructive Sleep Apnea (OSA) 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Office Based Clinics 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. South Asia 8.5. East Asia 8.6. Oceania 8.7. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Inspire Medical Systems 18.2. Respicardia, Inc. 18.3. Medtronic Plc 18.4. LinguaFlex LLC 18.5. Siesta Medical, Inc. 18.6. Avery biomedical 18.7. Nyxoah SA 18.8. LivaNova/ImThera 18.9. ASAHI KASEI CORP 18.10. SomnoMed 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Sleep Apnea Implants Market
